查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1940997

子癇前症檢測市場：市場洞察、競爭格局及預測（2033 年）

Preeclampsia Laboratory Testing Market Insights, Competitive Landscape, and Market Forecast - 2033
出版日期: | 出版商: Fairfield Market Research | 英文 191 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

全球子癇前症檢測市場預計將顯著成長，2026 年達到 14 億美元，2033 年達到 23 億美元，預測期內複合年增長率 (CAGR) 為 8.0%。人們對孕產婦健康併發症的認識不斷提高，加上診斷檢測技術的進步，預計將推動全球醫療機構採用子癇前症檢測。

市場洞察

子癇前症（簡稱子癇前症）是一種妊娠期高血壓疾病，是導致孕產婦和新生兒發病率和死亡率的重要因素。透過可靠的檢測方法進行早期發現對於控制病情和預防嚴重併發症（如子癇、器官損傷和早產）至關重要。基於尿液和血液檢測的診斷方法正變得越來越重要，有助於臨床醫生評估疾病的嚴重程度並在適當的時候進行幹預。

代謝組學生物標記和免疫測定等診斷技術的創新，進一步提高了子癇前症檢測的準確性和效率。這些技術進步，加上產前篩檢計畫的不斷增加，使醫療保健提供者能夠為高風險孕婦提供個人化照護。

市場驅動因素

子癇前症檢測市場的成長主要受以下關鍵因素驅動：

  • 1. 孕產婦健康意識的提高：世界各國政府和非政府組織都在推廣常規產前篩檢，包括子癇前症檢測，以降低孕產婦死亡率。這推動了對可靠診斷檢測的需求。
  • 2. 技術進步：高靈敏度血液和尿液檢測方法的開發，結合了用於早期檢測的生物標記物，使先兆子癇的診斷更加便捷和準確。
  • 3.妊娠高血壓疾病盛行率上升：流行病學研究表明，子癇前症的發生率不斷上升，尤其是在城市地區，這推動了對檢測的需求。
  • 4. 政府支持性政策和資金投入：對孕產婦保健基礎設施和產前保健計畫的投資，鼓勵醫療保健提供者採用先進的診斷工具進行疾病早期檢測。
  • 5. 與個人化醫療結合：實驗室正在利用新的生物標記來制定個人化的監測和介入策略，從而優化孕婦的整體護理路徑。

商機

該市場為診斷設備製造商和醫療保健提供者提供了廣泛的商機。主要業務前景包括：

  • 新興經濟體的擴張：亞太和拉丁美洲等地區產前保健計畫的擴展，為檢測設備製造商提供了重要的成長途徑。
  • 產品組合多元化：企業可以透過開發基於尿液和血液的診斷解決方案來抓住市場機遇，以應對不同嚴重程度的妊娠高血壓。
  • 策略聯盟與合作：診斷設備製造商與醫院和婦產科診所之間的合作可以擴大市場滲透率，並促進創新檢測方法的應用。
  • 研發投入：持續研究預測性生物標記和即時診斷解決方案可以提供市場競爭優勢。

區域分析

北美市場領先，這得益於其完善的醫療保健基礎設施、對孕產婦健康問題的廣泛關注以及大規模的研究計劃。該地區還受益於技術先進的實驗室診斷的高普及率。

歐洲預計將成為第二大市場，這得益於其完善的產前保健計劃和政府主導的促進疾病早期發現的舉措。

由於醫療保健支出增加、產前護理普及以及孕婦對妊娠併發症的認識提高，亞太市場預計將成長最快。

由於醫療保健基礎設施逐步改善以及公共和私營部門利益相關者對孕產婦健康的日益重視，拉丁美洲和中東及非洲市場預計將實現溫和增長。

主要參與者

全球子癇前症檢測市場競爭激烈，多家大型公司在產品開發和市場擴張方面處於領先地位。 主要公司包括：

  • DiabetOmics
  • DRG Instruments GmbH
  • Hoffmann-La Roche Ltd.
  • GestVision, Inc.
  • Lifeassay Diagnostics (Pty) Ltd.
  • Metabolomic Diagnostics
  • Perkin Elmer, Inc.
  • Progenity, Inc.
  • Quidel Corporation
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.

這些公司正透過創新的診斷平台、策略合作夥伴關係以及向新興地區的擴張來鞏固其市場地位。

市場區隔

子癇前症檢測市場可依據偵測類型、子癇前症類型、最終使用者和地理區域進行細分：

依檢測類型

  • 尿液檢測
  • 血液檢測

依子癇前症類型

  • 輕度
  • 重度

依最終使用者

  • 醫院和診所
  • 診斷中心
  • 其他

依地區

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

目錄目錄

第一章：摘要整理

第二章：市場概覽

  • 市場定義與細分
  • 市場動態
    • 驅動因素
    • 限制因素
    • 市場機遇
  • 價值鏈分析
  • 新冠疫情影響分析
  • 波特五力分析
  • 俄烏衝突的影響
  • PESTLE分析
  • 監理分析
  • 價格趨勢分析
    • 當前價格及未來預測（2025-2033年）
    • 價格影響因素

第三章：全球子癇前症檢測市場預測 2020-2033

  • 全球子癇前症市場預測，依檢測類型劃分，收入（十億美元），2020-2033
    • 尿液檢測
    • 血液檢測
  • 全球子癇前症檢測市場預測，以子癇前症類型劃分，收入（十億美元），2020-2033
    • 輕度
    • 重度
  • 全球子癇前症檢測市場預測，以最終用戶劃分，價值（十億美元），2020-2033
    • 醫院和診所
    • 診斷中心
  • 全球子癇前症市場預測，依地區劃分，價值（十億美元），2020-2033
    • 北美美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第四章：北美子癇前症檢測市場展望（2020-2033）

第五章：歐洲子癇前症檢測市場展望（2020-2033）

第六章：亞太地區子癇前症檢測市場展望（2020-2033）

第七章：拉丁美洲子癇前症檢測市場展望（2020-2033）

第八章：中東和非洲子癇前症檢測市場展望（2020-2033）

第九章：競爭格局概覽

  • 公司與細分市場熱力圖
  • 公司市佔率分析（2025 年）
  • 競爭格局概覽
  • 公司簡介
    • DiabetOmics
    • DRG Instruments GmbH
    • Hoffmann-La Roche Ltd.
    • GestVision, Inc.
    • Lifeassay Diagnostics (Pty) Ltd.
    • Metabolomic Diagnostics
    • Perkin Elmer, Inc.
    • Progenity, Inc.
    • Quidel Corporation
    • Siemens Healthineers

第十章附錄

簡介目錄

The global Preeclampsia Laboratory Testing Market is poised for substantial growth, with a projected valuation of USD 1.4 billion in 2026, expected to reach USD 2.3 billion by 2033, growing at a compound annual growth rate (CAGR) of 8.0% during the forecast period. Increasing awareness of maternal health complications, coupled with advancements in laboratory diagnostics, is set to drive the adoption of preeclampsia testing across healthcare settings worldwide.

Market Insights

Preeclampsia, a hypertensive disorder occurring during pregnancy, remains a significant contributor to maternal and neonatal morbidity and mortality. Early detection through reliable laboratory testing plays a crucial role in managing the condition and preventing severe complications such as eclampsia, organ damage, and preterm birth. The market is witnessing increasing emphasis on both urine and blood-based diagnostic assays, which help clinicians assess the severity of the disease and guide timely interventions.

Innovations in diagnostic technologies, including metabolomics-based biomarkers and immunoassays, are further enhancing the accuracy and efficiency of preeclampsia detection. Coupled with rising prenatal screening initiatives, these technological advancements are enabling healthcare providers to offer personalized care for at-risk pregnant women.

Market Drivers

The growth of the Preeclampsia Laboratory Testing Market is fueled by several key factors:

  • 1. Rising Maternal Health Awareness: Governments and NGOs worldwide are advocating for routine prenatal screenings, including preeclampsia testing, to reduce maternal mortality rates. This has led to increased demand for reliable laboratory diagnostics.
  • 2. Technological Advancements: The development of highly sensitive blood and urine tests, incorporating biomarkers for early detection, has made preeclampsia diagnostics more accessible and precise.
  • 3. Growing Prevalence of Hypertensive Disorders in Pregnancy: Epidemiological studies indicate an increasing incidence of preeclampsia, particularly in urban populations, which drives demand for laboratory testing.
  • 4. Supportive Government Policies and Funding: Investment in maternal healthcare infrastructure and prenatal care programs is encouraging healthcare providers to adopt advanced diagnostic tools for early disease detection.
  • 5. Integration with Personalized Medicine: Laboratories are leveraging novel biomarkers to customize monitoring and intervention strategies, enhancing the overall care pathway for pregnant women.

Business Opportunities

The market offers extensive opportunities for diagnostic manufacturers and healthcare providers. Key business prospects include:

  • Expansion in Emerging Economies: Growing prenatal care programs in regions like Asia Pacific and Latin America present a significant growth avenue for laboratory test manufacturers.
  • Product Portfolio Diversification: Companies can capitalize on developing both urine- and blood-based diagnostic solutions tailored to different preeclampsia severities.
  • Strategic Collaborations and Partnerships: Partnerships between diagnostics companies and hospitals or prenatal clinics can enhance market reach and streamline adoption of innovative tests.
  • Investment in R&D: Continuous research into predictive biomarkers and point-of-care diagnostic solutions can offer a competitive advantage in the market.

Regional Analysis

North America dominates the market owing to well-established healthcare infrastructure, widespread awareness of maternal health issues, and extensive research initiatives. The region also benefits from high adoption of technologically advanced laboratory diagnostics.

Europe follows closely, supported by robust prenatal care programs and government-led initiatives promoting early disease detection.

The Asia Pacific market is expected to witness the fastest growth due to increasing healthcare expenditure, expanding prenatal care coverage, and rising awareness of maternal complications among pregnant women.

Latin America and the Middle East & Africa are anticipated to see moderate growth, driven by gradual improvements in healthcare infrastructure and increasing focus on maternal health by public and private stakeholders.

Key Players

The global preeclampsia laboratory testing market is highly competitive, with several prominent companies leading product development and market expansion initiatives. Key players include:

  • DiabetOmics
  • DRG Instruments GmbH
  • Hoffmann-La Roche Ltd.
  • GestVision, Inc.
  • Lifeassay Diagnostics (Pty) Ltd.
  • Metabolomic Diagnostics
  • Perkin Elmer, Inc.
  • Progenity, Inc.
  • Quidel Corporation
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.

These companies are focusing on innovative diagnostic platforms, strategic collaborations, and expansion into emerging regions to strengthen their market presence.

Market Segmentation

The Preeclampsia Laboratory Testing Market can be segmented based on test type, preeclampsia type, end user, and geographic coverage:

By Test Type

  • Urine Tests
  • Blood Tests

By Preeclampsia Type

  • Mild Preeclampsia
  • Severe Preeclampsia

By End User

  • Hospitals and Clinics
  • Diagnostic Centres
  • Others

By Geographic Coverage

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Preeclampsia Laboratory Testing Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Fiver Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Preeclampsia Laboratory Testing Market Outlook, 2020-2033

  • 3.1. Global Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
    • 3.1.1. Urine Tests
    • 3.1.2. Blood Tests
  • 3.2. Global Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, Value (US$ Bn), 2020-2033
    • 3.2.1. Mild Preeclampsia
    • 3.2.2. Severe Preeclampsia
  • 3.3. Global Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 3.3.1. Hospitals and Clinics
    • 3.3.2. Diagnostic Centres
  • 3.4. Global Preeclampsia Laboratory Testing Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.4.1. North America
    • 3.4.2. Europe
    • 3.4.3. Asia Pacific
    • 3.4.4. Latin America
    • 3.4.5. Middle East & Africa

4. North America Preeclampsia Laboratory Testing Market Outlook, 2020-2033

  • 4.1. North America Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
    • 4.1.1. Urine Tests
    • 4.1.2. Blood Tests
  • 4.2. North America Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, Value (US$ Bn), 2020-2033
    • 4.2.1. Mild Preeclampsia
    • 4.2.2. Severe Preeclampsia
  • 4.3. North America Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 4.3.1. Hospitals and Clinics
    • 4.3.2. Diagnostic Centres
  • 4.4. North America Preeclampsia Laboratory Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.4.1. U.S. Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 4.4.2. U.S. Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 4.4.3. U.S. Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 4.4.4. Canada Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 4.4.5. Canada Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 4.4.6. Canada Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
  • 4.5. BPS Analysis/Market Attractiveness Analysis

5. Europe Preeclampsia Laboratory Testing Market Outlook, 2020-2033

  • 5.1. Europe Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
    • 5.1.1. Urine Tests
    • 5.1.2. Blood Tests
  • 5.2. Europe Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, Value (US$ Bn), 2020-2033
    • 5.2.1. Mild Preeclampsia
    • 5.2.2. Severe Preeclampsia
  • 5.3. Europe Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 5.3.1. Hospitals and Clinics
    • 5.3.2. Diagnostic Centres
  • 5.4. Europe Preeclampsia Laboratory Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.4.1. Germany Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 5.4.2. Germany Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 5.4.3. Germany Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 5.4.4. Italy Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 5.4.5. Italy Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 5.4.6. Italy Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 5.4.7. France Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 5.4.8. France Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 5.4.9. France Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 5.4.10. U.K. Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 5.4.11. U.K. Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 5.4.12. U.K. Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 5.4.13. Spain Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 5.4.14. Spain Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 5.4.15. Spain Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 5.4.16. Russia Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 5.4.17. Russia Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 5.4.18. Russia Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 5.4.19. Rest of Europe Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 5.4.20. Rest of Europe Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 5.4.21. Rest of Europe Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
  • 5.5. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, 2020-2033

  • 6.1. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
    • 6.1.1. Urine Tests
    • 6.1.2. Blood Tests
  • 6.2. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, Value (US$ Bn), 2020-2033
    • 6.2.1. Mild Preeclampsia
    • 6.2.2. Severe Preeclampsia
  • 6.3. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 6.3.1. Hospitals and Clinics
    • 6.3.2. Diagnostic Centres
  • 6.4. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.4.1. China Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 6.4.2. China Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 6.4.3. China Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 6.4.4. Japan Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 6.4.5. Japan Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 6.4.6. Japan Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 6.4.7. South Korea Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 6.4.8. South Korea Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 6.4.9. South Korea Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 6.4.10. India Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 6.4.11. India Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 6.4.12. India Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 6.4.13. Southeast Asia Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 6.4.14. Southeast Asia Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 6.4.15. Southeast Asia Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 6.4.16. Rest of SAO Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 6.4.17. Rest of SAO Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 6.4.18. Rest of SAO Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
  • 6.5. BPS Analysis/Market Attractiveness Analysis

7. Latin America Preeclampsia Laboratory Testing Market Outlook, 2020-2033

  • 7.1. Latin America Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
    • 7.1.1. Urine Tests
    • 7.1.2. Blood Tests
  • 7.2. Latin America Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, Value (US$ Bn), 2020-2033
    • 7.2.1. Mild Preeclampsia
    • 7.2.2. Severe Preeclampsia
  • 7.3. Latin America Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 7.3.1. Hospitals and Clinics
    • 7.3.2. Diagnostic Centres
  • 7.4. Latin America Preeclampsia Laboratory Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.4.1. Brazil Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 7.4.2. Brazil Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 7.4.3. Brazil Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 7.4.4. Mexico Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 7.4.5. Mexico Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 7.4.6. Mexico Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 7.4.7. Argentina Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 7.4.8. Argentina Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 7.4.9. Argentina Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 7.4.10. Rest of LATAM Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 7.4.11. Rest of LATAM Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 7.4.12. Rest of LATAM Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
  • 7.5. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, 2020-2033

  • 8.1. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
    • 8.1.1. Urine Tests
    • 8.1.2. Blood Tests
  • 8.2. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, Value (US$ Bn), 2020-2033
    • 8.2.1. Mild Preeclampsia
    • 8.2.2. Severe Preeclampsia
  • 8.3. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 8.3.1. Hospitals and Clinics
    • 8.3.2. Diagnostic Centres
  • 8.4. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.4.1. GCC Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 8.4.2. GCC Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 8.4.3. GCC Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 8.4.4. South Africa Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 8.4.5. South Africa Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 8.4.6. South Africa Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 8.4.7. Egypt Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 8.4.8. Egypt Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 8.4.9. Egypt Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 8.4.10. Nigeria Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 8.4.11. Nigeria Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 8.4.12. Nigeria Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
    • 8.4.13. Rest of Middle East Preeclampsia Laboratory Testing Market Outlook, by Test Type, 2020-2033
    • 8.4.14. Rest of Middle East Preeclampsia Laboratory Testing Market Outlook, by Preeclampsia Type, 2020-2033
    • 8.4.15. Rest of Middle East Preeclampsia Laboratory Testing Market Outlook, by End User, 2020-2033
  • 8.5. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. DiabetOmics
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. DRG Instruments GmbH
    • 9.4.3. Hoffmann-La Roche Ltd.
    • 9.4.4. GestVision, Inc.
    • 9.4.5. Lifeassay Diagnostics (Pty) Ltd.
    • 9.4.6. Metabolomic Diagnostics
    • 9.4.7. Perkin Elmer, Inc.
    • 9.4.8. Progenity, Inc.
    • 9.4.9. Quidel Corporation
    • 9.4.10. Siemens Healthineers

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations